Validation of the Ability of ESER Score to Predict Recurrent Stroke: a Meta-Analysis

chengju liao,zhe luo,ying ru,jian yang,chenghong luo,weiheng lu,lunjiao fu
DOI: https://doi.org/10.5114/aoms/127199
2021-01-01
Abstract:Purpose: A risk stratification model is pretty important to prevent the recurrent stroke for ischemic stroke patients. The present study aimed to meta-analysis the ability of Essen Stroke Risk Score (ESRS) to accurately predict recurrence of ischemic stroke. Methods: Studies on the diagnostic performance of ESRS in predicting recurrent stroke were searched by electronic and manual methods. Quality pooled C-statistics, and 95% confidence intervals (95% CI) were evaluated. Results: Fifteen studies with a total of 94,052 patients were included in the meta-analysis. The pooled C-statistics of ESER for patients without atrial fibrillation (AF) experiencing recurring strokes at 90-day or one-year were 0.65 (95% CI: 0.58-0.73) and 0.57 (95% CI: 0.53-0.60), and the heterogeneity was weak. The average ratio of one-year recurrent stroke in the low-risk and high-risk groups classified according to ESRS is 5.6%(range 1.4 to 12.1%) and 9.2%( range 3.2 to 20.1%), respectively. And the calibration analysis showed the pooled RR in the low-risk group is 0.88 (95%CI: 0.24-3.19) and 0.88 (0.24-3.31) with wide confidence intervals and high levels of heterogeneity, indicating the calibration ability was low. Conclusion: ESRS had low to moderate ability to predict recurrence of stroke in patients with ischemic stroke and low calibration ability, which need to be further improved.
What problem does this paper attempt to address?